168 related articles for article (PubMed ID: 22862735)
1. Association between glycemic control and hip fracture.
Puar TH; Khoo JJ; Cho LW; Xu Y; Chen YT; Chuo AM; Poh CB; Ng JM
J Am Geriatr Soc; 2012 Aug; 60(8):1493-7. PubMed ID: 22862735
[TBL] [Abstract][Full Text] [Related]
2. Glycated Hemoglobin Level and Risk of Hip Fracture in Older People with Type 2 Diabetes: A Competing Risk Analysis of Taiwan Diabetes Cohort Study.
Li CI; Liu CS; Lin WY; Meng NH; Chen CC; Yang SY; Chen HJ; Lin CC; Li TC
J Bone Miner Res; 2015 Jul; 30(7):1338-46. PubMed ID: 25598134
[TBL] [Abstract][Full Text] [Related]
3. HbA1c variability, in addition to mean HbA1c, predicts incident hip fractures in Chinese people with type 2 diabetes.
Lui DTW; Lee CH; Chan YH; Chow WS; Fong CHY; Siu DCW; Tse HF; Woo YC; Lam KSL
Osteoporos Int; 2020 Oct; 31(10):1955-1964. PubMed ID: 32385660
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Glycated Hemoglobin in Frail Older Diabetic Patients With Hip Fracture.
Paterni S; Okoye C; Calabrese AM; Niccolai F; Polini A; Caraccio N; Calsolaro V; Monzani F
Front Endocrinol (Lausanne); 2021; 12():770400. PubMed ID: 34867813
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database.
Bae JP; Duan R; Fu H; Hoogwerf BJ
Clin Ther; 2017 Sep; 39(9):1790-1798.e7. PubMed ID: 28781218
[TBL] [Abstract][Full Text] [Related]
6. Glycemic Control and Insulin Treatment Alter Fracture Risk in Older Men With Type 2 Diabetes Mellitus.
Lee RH; Sloane R; Pieper C; Lyles KW; Adler RA; Van Houtven C; LaFleur J; Colón-Emeric C
J Bone Miner Res; 2019 Nov; 34(11):2045-2051. PubMed ID: 31269274
[TBL] [Abstract][Full Text] [Related]
7. The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China.
Bi Y; Zhu D; Cheng J; Zhu Y; Xu N; Cui S; Li W; Cheng X; Wang F; Hu Y; Shen S; Weng J
Clin Ther; 2010 May; 32(5):973-83. PubMed ID: 20685506
[TBL] [Abstract][Full Text] [Related]
8. Use of Intensive Glycemic Management in Older Adults with Diabetes Mellitus.
Arnold SV; Lipska KJ; Wang J; Seman L; Mehta SN; Kosiborod M
J Am Geriatr Soc; 2018 Jul; 66(6):1190-1194. PubMed ID: 29633237
[TBL] [Abstract][Full Text] [Related]
9. Antidiabetic Treatment, Level of Glycemic Control, and Risk of Fracture in Type 2 Diabetes: a Nested, Case-Control Study.
Charlier S; Vavanikunnel J; Becker C; Jick SS; Meier C; Meier CR
J Clin Endocrinol Metab; 2021 Jan; 106(2):554-566. PubMed ID: 33141149
[TBL] [Abstract][Full Text] [Related]
10. Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes.
McCoy RG; Lipska KJ; Van Houten HK; Shah ND
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32075810
[TBL] [Abstract][Full Text] [Related]
11. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control.
Lipska KJ; Ross JS; Miao Y; Shah ND; Lee SJ; Steinman MA
JAMA Intern Med; 2015 Mar; 175(3):356-62. PubMed ID: 25581565
[TBL] [Abstract][Full Text] [Related]
12. Mortality after hip fracture in diabetic patients.
Gulcelik NE; Bayraktar M; Caglar O; Alpaslan M; Karakaya J
Exp Clin Endocrinol Diabetes; 2011 Jul; 119(7):414-8. PubMed ID: 21553363
[TBL] [Abstract][Full Text] [Related]
13. Correlation of long-term glycemic control as measured by glycated hemoglobin with serum angiopoietin-like 6 protein levels in type 2 diabetes mellitus patients.
Sharma V; Pangtey GS; Gupta R; Rehan HS; Gupta LK
Indian J Pharmacol; 2017; 49(3):250-253. PubMed ID: 29033485
[TBL] [Abstract][Full Text] [Related]
14. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
[TBL] [Abstract][Full Text] [Related]
15. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á
JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415
[TBL] [Abstract][Full Text] [Related]
16. Glycemic and non-glycemic targets in younger and older North Indian subjects with type 2 diabetes in a Tertiary care hospital: A 10 year's retrospective data analysis.
Ahmad J; Zubair M; Malik N; D Z; Raghav A
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S130-4. PubMed ID: 26564028
[TBL] [Abstract][Full Text] [Related]
17. Association Between Glycemic Control and Risk of Fracture in Diabetic Patients: A Nested Case-Control Study.
Vavanikunnel J; Charlier S; Becker C; Schneider C; Jick SS; Meier CR; Meier C
J Clin Endocrinol Metab; 2019 May; 104(5):1645-1654. PubMed ID: 30657918
[TBL] [Abstract][Full Text] [Related]
18. HbA1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes.
Zeitler P; Hirst K; Copeland KC; El Ghormli L; Levitt Katz L; Levitsky LL; Linder B; McGuigan P; White NH; Wilfley D;
Diabetes Care; 2015 Dec; 38(12):2285-92. PubMed ID: 26537182
[TBL] [Abstract][Full Text] [Related]
19. Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial.
Josse RG; Majumdar SR; Zheng Y; Adler A; Bethel MA; Buse JB; Green JB; Kaufman KD; Rodbard HW; Tankova T; Westerhout CM; Peterson ED; Holman RR; Armstrong PW;
Diabetes Obes Metab; 2017 Jan; 19(1):78-86. PubMed ID: 27607571
[TBL] [Abstract][Full Text] [Related]
20. Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.
Billings LK; Parkin CG; Price D
Diabetes Technol Ther; 2018 Aug; 20(8):561-565. PubMed ID: 30044123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
